Manufacturer
104 recalls in our database name Wells Pharmacy Network, LLC as the manufacturing or recalling firm.
Of the 104 recalls from Wells Pharmacy Network, LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 93 (89%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Wells Pharmacy Network LLC is recalling 41 syringes of Mitomycin Solution Injectable because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling 237 vials of Vitamin D3 in Sesame Oil Injectable due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 511 vials of a compounded injectable drug due to a lack of assurance of sterility. The product was distributed nationwide.
Wells Pharmacy Network LLC is recalling 16 vials of Dexamethasone Sodium Phosphate 24 mg/mL injectable due to a lack of assurance of sterility.
Wells Pharmacy is recalling Testosterone Cypionate in Grapeseed Oil Injectable vials because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling QUAD1 injectable vials because the FDA determined there is a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Trimix Injectable vials because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling 984 vials of MIC/B-Complex Injectable because the product lacks assurance of sterility.
Wells Pharmacy Network LLC is recalling 147 vials of a compounded injectable drug due to a lack of assurance of sterility. The products were distributed nationwide.
Wells Pharmacy Network LLC is recalling QUAD4 injectable vials because the FDA determined there is a lack of assurance of sterility.
Wells Pharmacy Network is recalling Arginine/Citrulline/Ornit+Lido injectable vials due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 131 kits of Indocyanine Green (P.F.) 15 mg Injectable due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Trimix Injectable vials because the product may lack assurance of sterility.
Wells Pharmacy Network LLC is recalling Methylcobalamin Injectable kits due to a lack of assurance of sterility. The recall covers kits prepared between February 2016 and September 2016.
Wells Pharmacy Network LLC is recalling specific vials of Trimix Injectable because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling 1,250 vials of compounded Testosterone Enanthate Injectable nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 203 vials of compounded Testosterone Cypionate/Anastrozole Injectable nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 203 kits of compounded Fluorescein/Indocyanine Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Tri 1 (PAP/PHEN/ATROPINE) NR Injectable vials because the product lacks assurance of sterility.
Wells Pharmacy Network LLC is recalling 933 vials of MIC/B-COMP/(M)/CHROM/CARN Injectable due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Trimix Injectable vials because the agency could not ensure the product was sterile. The recall covers vials prepared between February 2016 and September 2016.
Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP (2) Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 22 vials of a compounded injectable drug due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 67 vials of Sodium Bicarbonate, 8.4% Injectable, due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP Injectable Kits nationwide due to a lack of assurance of sterility.